PB2 and Hemagglutinin Mutations Are Major Determinants of Host Range and Virulence in Mouse-adapted Influenza A Virus
Overview
Affiliations
Serial mouse lung passage of a human influenza A virus, A/Hong Kong/1/68 (H3N2) (HK-wt), produced a mouse-adapted variant, MA, with nine mutations that was >10(3.8)-fold more virulent. In this study, we demonstrate that MA mutations of the PB2 (D701N) and hemagglutinin (HA) (G218W in HA1 and T156N in HA2) genes were the most adaptive genetic determinants for increased growth and virulence in the mouse model. Recombinant viruses expressing each of the mutated MA genome segments on the HK-wt backbone showed significantly increased disease severity, whereas only the mouse-adapted PB2 gene increased virulence, as determined by the 50% lethal dose ([LD(50)] >10(1.4)-fold). The converse comparisons of recombinant MA viruses expressing each of the HK-wt genome segments showed the greatest decrease in virulence due to the HA gene (10(2)-fold), with lesser decreases due to the M1, NS1, NA, and PB1 genes (10(0.3)- to 10(0.8)-fold), and undetectable effects on the LD(50) for the PB2 and NP genes. The HK PB2 gene did, however, attenuate MA infection, as measured by weight loss and time to death. Replication of adaptive mutations in vivo and in vitro showed both viral gene backbone and host range effects. Minigenome transcription assays showed that PB1 and PB2 mutations increased polymerase activity and that the PB2 D701N mutation was comparable in effect to the mammalian adaptive PB2 E627K mutation. Our results demonstrate that host range and virulence are controlled by multiple genes, with major roles for mutations in PB2 and HA.
Influenza virus evolution and defective genome formation are shaped by host genotype and sex.
Costa R, Acosta-Alvarez L, Curtis K, Zarbock K, Kelleher J, Lamichhane B bioRxiv. 2025; .
PMID: 40060519 PMC: 11888471. DOI: 10.1101/2025.02.26.638946.
ARNT Inhibits H5N1 Influenza A Virus Replication by Interacting with the PA Protein.
Feng H, Wang Z, Zhu P, Wu L, Shi J, Li Y Viruses. 2022; 14(7).
PMID: 35891329 PMC: 9318437. DOI: 10.3390/v14071347.
Yang F, Zhang X, Liu F, Yao H, Wu N, Wu H Virus Genes. 2022; 58(5):473-477.
PMID: 35616824 DOI: 10.1007/s11262-022-01911-x.
Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
Chen N, Zhang B, Deng L, Liang B, Ping J Emerg Microbes Infect. 2022; 11(1):1371-1389.
PMID: 35476817 PMC: 9132403. DOI: 10.1080/22221751.2022.2071175.
Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses.
Al Farroukh M, Kiseleva I, Bazhenova E, Stepanova E, Puchkova L, Rudenko L Vaccines (Basel). 2022; 10(3).
PMID: 35335027 PMC: 8954537. DOI: 10.3390/vaccines10030395.